{"transactions":[{"id":1027461,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":123,"price":47.0133,"value":5782.6359,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $47.00 to $47.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":764127,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027460,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":177,"price":47.0133,"value":8321.3541,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $47.00 to $47.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1050599,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027459,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":57502,"price":46.4068,"value":2668483.8136,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $46.00 to $46.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":764250,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027458,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":83066,"price":46.4068,"value":3854827.2488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $46.00 to $46.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1050776,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027457,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":34405,"price":45.3547,"value":1560428.4535,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $45.00 to $45.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":821752,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1027456,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:40:04.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":49701,"price":45.3547,"value":2254173.9447,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $45.00 to $45.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1133842,"source":{"system":"sec-edgar","filing":"0001193125-25-228493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525228493/ownership.xml","form_type":"4"}},{"id":1034668,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":132,"price":43.3,"value":5715.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":856157,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034667,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":268,"price":43.3,"value":11604.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1183543,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034666,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":20148,"price":43.0038,"value":866440.5624,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.25 to $43.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":856289,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034665,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":40907,"price":43.0038,"value":1759156.4466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.25 to $43.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1183811,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034664,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":24370,"price":41.5908,"value":1013567.796,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $41.25 to $42.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":876437,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1034663,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T20:23:19.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":49479,"price":41.5908,"value":2057871.1932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $41.25 to $42.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1224718,"source":{"system":"sec-edgar","filing":"0001193125-25-211363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000119312525211363/ownership.xml","form_type":"4"}},{"id":1055814,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":1707,"price":39.5022,"value":67430.2554,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.49 to $39.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":900807,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055813,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":3465,"price":39.5022,"value":136875.123,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.49 to $39.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1274197,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055812,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":21661,"price":38.9744,"value":844224.4784,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.50 to $39.485, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":902514,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055811,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":43978,"price":38.9744,"value":1714016.1632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.50 to $39.485, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1277662,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055810,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":1058,"price":39.9212,"value":42236.6296,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.81 to $40.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":924175,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055809,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":2149,"price":39.9212,"value":85790.6588,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.81 to $40.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1321640,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055808,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":24760,"price":39.5255,"value":978651.38,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.815 to $39.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":925233,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055807,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":50270,"price":39.5255,"value":1986946.885,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.815 to $39.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1323789,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055806,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":2809,"price":40.5899,"value":114017.0291,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $40.50 to $40.8819, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":949993,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055805,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":5668,"price":40.5899,"value":230063.5532,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $40.50 to $40.8819, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1374059,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055804,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":10076,"price":40.0297,"value":403339.2572,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.5085 to $40.4616, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":952802,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1055803,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T23:59:49.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":20493,"price":40.0297,"value":820328.6421,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $39.5085 to $40.4616, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1379727,"source":{"system":"sec-edgar","filing":"0000950170-25-111529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025111529/ownership.xml","form_type":"4"}},{"id":1061958,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":15085,"price":38.5611,"value":581694.1935,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.26 to $39.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":962878,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1061957,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":30628,"price":38.5611,"value":1181049.3708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.26 to $39.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1400220,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1061956,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":69949,"price":39.5,"value":2762985.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":977963,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1061955,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:51:33.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":145051,"price":39.5,"value":5729514.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1430848,"source":{"system":"sec-edgar","filing":"0000950170-25-110163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025110163/ownership.xml","form_type":"4"}},{"id":1088074,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-14T20:50:19.000Z","date":"2025-07-10","kind":"sale","planned":false,"acquired":false,"shares":191376,"price":34,"value":6506784.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1575899,"source":{"system":"sec-edgar","filing":"0000950170-25-095616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025095616/ownership.xml","form_type":"4"}},{"id":1097972,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-01T22:16:12.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":30.465,"value":6093000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.18 to $30.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1767275,"source":{"system":"sec-edgar","filing":"0000950170-25-092373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025092373/ownership.xml","form_type":"4"}},{"id":1105091,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:50:38.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":133924,"price":30.25,"value":4051201.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC\nVI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary\ninterests therein."}],"balance_after":1967275,"source":{"system":"sec-edgar","filing":"0000950170-25-088604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025088604/ownership.xml","form_type":"4"}},{"id":1105090,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:50:38.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":100877,"price":30.35,"value":3061616.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1047912,"source":{"system":"sec-edgar","filing":"0000950170-25-088604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025088604/ownership.xml","form_type":"4"}},{"id":1105089,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:50:38.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":29.95,"value":2995000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1148789,"source":{"system":"sec-edgar","filing":"0000950170-25-088604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025088604/ownership.xml","form_type":"4"}},{"id":1113608,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:37:21.000Z","date":"2025-06-10","kind":"sale","planned":false,"acquired":false,"shares":350000,"price":29,"value":10150000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Versant Venture Capital VII, L.P. (\"VVC VII\"). Versant Ventures VII GP-GP, LLC (\"VV VII GP\") is the sole general partner of Versant Ventures VII GP, L.P. (\"VV VII\") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":1248789,"source":{"system":"sec-edgar","filing":"0000950170-25-085490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017025085490/ownership.xml","form_type":"4"}},{"id":1561958,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":7,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74650,"kind":"organization","name":"Versant Ventures VII GP, L.P.","position":8,"cik":"0001777655","reported_name":"Versant Ventures VII GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74651,"kind":"organization","name":"Versant Ventures VII GP-GP, LLC","position":9,"cik":"0001777656","reported_name":"Versant Ventures VII GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-25T20:30:48.000Z","date":"2024-03-21","kind":"other","planned":false,"acquired":true,"shares":598203,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer (\"Merger Sub\"), and Lenz Therapeutics, Inc., a Delaware corporation (\"LENZ\"), pursuant to which the Merger Sub merged with and into LENZ (the \"Merger\"), with LENZ continuing as a wholly owned subsidiary of the Issuer and the surviving corporation of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer (\"Merger Sub\"), and Lenz Therapeutics, Inc., a Delaware corporation (\"LENZ\"), pursuant to which the Merger Sub merged with and into LENZ (the \"Merger\"), with LENZ continuing as a wholly owned subsidiary of the Issuer and the surviving corporation of the Merger."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective March 21, 2024, prior to the closing of the Merger, the Issuer effected a one-for-seven reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Versant Vantage II, L.P. (\"VV II\"). Versant Vantage II GP-GP, LLC (\"VV II GP-GP\") is the sole general partner of Versant Vantage II GP, L.P. (\"VV II GP\") and VV II GP is the sole general partner of VV II. Each of VV II GP-GP and VV II GP disclaims beneficial ownership of the shares held by VV II, except to the extent of their respective pecuniary interests therein."}],"balance_after":842162,"source":{"system":"sec-edgar","filing":"0000950170-24-035951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017024035951/ownership.xml","form_type":"4"}},{"id":2302625,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":11726,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP-GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VII GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP-GP. Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Ventures VII GP-GP, except to the extent of his pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302624,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":true,"shares":11726,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Ventures VII GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VII GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VII GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP-GP. Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Ventures VII GP-GP, except to the extent of his pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":11726,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302623,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":14194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VII GP. Versant Ventures VII GP-GP is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP. Each of Versant Ventures VII GP-GP and Jerel C. Davis disclaim beneficial ownership of the shares held by Versant Ventures VII GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302622,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":true,"shares":14194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures VII GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VII."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VII GP. Versant Ventures VII GP-GP is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP. Each of Versant Ventures VII GP-GP and Jerel C. Davis disclaim beneficial ownership of the shares held by Versant Ventures VII GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":14194,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2302621,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:38:37.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":709953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VII, L.P. (\"Versant VII\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. (\"Versant Ventures VII GP\") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC (\"Versant Ventures VII GP-GP\") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant Ventures VII GP-GP, Versant Ventures VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2913070,"source":{"system":"sec-edgar","filing":"0000899243-22-014108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322014108/doc4.xml","form_type":"4"}},{"id":2444210,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:16:02.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":92000,"price":16.0002,"value":1472018.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Venture Capital VII, L.P. (\"Versant VII\"), Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") and Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are held of record by Versant I Parallel. Versant Voyageurs I GP, L.P. (\"Versant Voyageurs I GP\") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant Voyageurs I GP. Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP, Versant Voyageurs I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant I Parallel, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":552149,"source":{"system":"sec-edgar","filing":"0000899243-22-000946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322000946/doc4.xml","form_type":"4"}},{"id":2444209,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:16:02.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":308000,"price":16.0002,"value":4928061.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Venture Capital VII, L.P. (\"Versant VII\"), Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") and Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by Versant Voyageurs I. Versant Voyageurs I GP Company is the general partner of Versant Voyageurs I. Jerel C. Davis, a member of the Issuer's board of directors, is a director of Versant Voyageurs I GP Company and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I. Each of Versant Voyageurs I GP Company and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Voyageurs I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1863197,"source":{"system":"sec-edgar","filing":"0000899243-22-000946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322000946/doc4.xml","form_type":"4"}},{"id":2444208,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:16:02.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":600000,"price":16.0002,"value":9600120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Venture Capital VII, L.P. (\"Versant VII\"), Versant Voyageurs I, L.P. (\"Versant Voyageurs I\") and Versant Voyageurs I Parallel, L.P. (\"Versant I Parallel\"), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. (\"Versant Ventures VII GP\") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC (\"Versant Ventures VII GP-GP\") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant VII GP-GP, Versant VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3623023,"source":{"system":"sec-edgar","filing":"0000899243-22-000946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924322000946/doc4.xml","form_type":"4"}},{"id":2585215,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T19:06:18.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":78098,"price":14,"value":1093372.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Versant Voyageurs I Parallel L.P. (\"Versant I Parallel\"). Versant Voyageurs I GP, L.P. (\"Versant Voyageurs I GP\") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant Voyageurs I GP. Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP, Versant Voyageurs I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant I Parallel, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":644149,"source":{"system":"sec-edgar","filing":"0000899243-21-034627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924321034627/doc4.xml","form_type":"4"}},{"id":2585214,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T19:06:18.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":261902,"price":14,"value":3666628.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Versant Voyageurs I, L.P. (\"Versant Voyageurs I\"). Versant Voyageurs I GP Company is the general partner of Versant Voyageurs I. Jerel C. Davis, a member of the Issuer's board of directors, is a director of Versant Voyageurs I GP Company and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I. Each of Versant Voyageurs I GP Company and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant Voyageurs I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2171197,"source":{"system":"sec-edgar","filing":"0000899243-21-034627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924321034627/doc4.xml","form_type":"4"}},{"id":2585213,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":74649,"kind":"organization","name":"Versant Venture Capital VII, L.P.","position":1,"cik":"0001750266","reported_name":"Versant Venture Capital VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87880,"kind":"organization","name":"Versant Voyageurs I, L.P.","position":2,"cik":"0001745960","reported_name":"Versant Voyageurs I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87881,"kind":"organization","name":"Versant Voyageurs I Parallel, L.P.","position":3,"cik":"0001745961","reported_name":"Versant Voyageurs I Parallel, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T19:06:18.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":510000,"price":14,"value":7140000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held of record by Versant Venture Capital VII, L.P. (\"Versant VII\"). Versant Ventures VII GP, L.P. (\"Versant Ventures VII GP\") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC (\"Versant Ventures VII GP-GP\") is the general partner of Versant Ventures VII GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant VII GP-GP, Versant VII GP and Jerel C. Davis disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4223023,"source":{"system":"sec-edgar","filing":"0000899243-21-034627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745960/000089924321034627/doc4.xml","form_type":"4"}}]}